Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in CA
NPI: 1104876952HQ Phone
Get M.D. William's Phone Numberphone_androidMobile
Get M.D. William's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1983 - 2026
MN State Medical License
1981 - 1981
American Board of Internal Medicine
Internal Medicine
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Hematology and Medical Oncology
1982 - 1985
University of Minnesota
Residency • Internal Medicine
1978 - 1981
Cleveland Medical College, Homeopathic
case.edu
Medical School
Until 1978
A second isolate of HTLV-II associated with atypical hairy-cell leukemia.
Authors: Isan Chen, Joseph Rosenblatt
Journal: N Engl J Med
Pilot Trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma.
Authors: Richard Ambinder, Ronald Mitsuyasu, Mark Dickson, David Aboulafia
Publication Date: 2019-03-28
The x gene is essential for HTLV replication.
Authors: Isan Chen, Dennis Slamon, Neil Shah, Joseph Rosenblatt
Journal: Science
Lead Sponsor: AIDS Malignancy Consortium
Collaborators: Vasgene Therapeutics, Inc, National Cancer Institute (NCI), The Emmes Company, LLC, University of Arkansas
Intervention / Treatment: BIOLOGICAL: Recombinant EphB4-HSA Fusion Protein, OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, BEHAVIORAL: Quality-of-Life Assessment
Lead Sponsor: AIDS Malignancy Consortium
Collaborators: University of California, San Diego, National Cancer Institute (NCI), University of Arkansas
Intervention / Treatment: OTHER: Medical Chart Review, GENETIC: Laboratory Biomarker Analysis
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, PROCEDURE: Bone Marrow Biopsy, BIOLOGICAL: Ipilimumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, PROCEDURE: Computed Tomography